New COVID-19 Test to Treat Initiative and Locator Tool

HHS/ASPR Program Provides Individuals with Faster, Easier Access to Life-saving COVID-19 Testing and Treatment in the Same Location
A new federal Test to Treat program gives people a fast and easy way to get lifesaving treatment for COVID-19. In this program, people can get tested at Test to Treat sites. If they test positive and treatments are appropriate for them, they can get a prescription from a healthcare provider and have the prescription filled all in one location. People can also bring test results obtained from a home testing kit to Test to Treat sites and get evaluated by a healthcare provider for treatment. These one-stop Test to Treat sites are available nationwide at hundreds of pharmacy-based clinics and Health Resources and Services Administration (HRSA)-supported federally qualified health centers (FQHCs).

In addition, the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) launched a new COVID-19 Test to Treat Locator. People can use this web-based tool to find Test to Treat sites near them. 

Oral antiviral pills from Merck (Lagevrio) and Pfizer (Paxlovid) are available at Test to Treat sites. The Test to Treat program does not change existing requirements for qualified healthcare providers to write the prescriptions for these medications. In addition, people can continue to get tested and treated by their own healthcare providers, who can prescribe these oral antivirals to eligible patients. Patients can pick up those prescriptions wherever oral antivirals are distributed. 

If these oral antivirals are inappropriate for patients, additional COVID-19 therapeutic options outside the Test to Treat program are available. The National Institutes of Health (NIH) has developed and regularly updates Treatment Guidelines to help guide healthcare providers caring for patients with COVID-19. 

To learn more, visit: 
The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA Products. 
For information about this update or other clinical issues, or to send your feedback, please contact us at
Clinician Outreach and Communication Activity—resources for healthcare providers
COCA RSS Feed—subscribe to be notified of conference calls, updates, and CDC guidance for health providers
Crisis & Emergency Risk Communication Training—training program that draws from lessons learned during public health emergencies, and incorporates best practices from the fields of risk and crisis communication
Health Alert Network—CDC's primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, and local public health practitioners; clinicians; and public health laboratories

CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe